ZYUS Life Sciences Announces Closing of First Tranche of Unit Offering May 6, 2025 09:04PM
ZYUS Life Sciences Further Expands Global Intellectual Property Portfolio with Issuance of EU Patent covering Trichomylin® Formulation and Announces Unit Offering May 1, 2025 07:00AM
ZYUS Life Sciences Corporation Announces Issuance of Bonus Warrants Pursuant to Loan Agreements Apr 11, 2025 06:21PM
ZYUS Life Sciences Corporation Announces Assumption and Amendment of Promissory Note Mar 17, 2025 07:00AM
ZYUS Life Sciences Corporation Announces Close of Unsecured Loan and Amendment to Prior Unsecured Loans Mar 10, 2025 07:00AM


Dec 23, 2024 07:00AM ZYUS Life Sciences Corporation Announces Closing of Unsecured Loan and Amendment of Existing Shareholder Promissory Note
Nov 4, 2024 07:00AM ZYUS Life Sciences Corporation Announces Unsecured Loan
Sep 27, 2024 11:44PM ZYUS Life Sciences Corporation Announces Closing of Unsecured Loan
Aug 26, 2024 10:23PM ZYUS Life Sciences Announces Closing of Private Placement
Jul 30, 2024 07:00AM ZYUS Life Sciences Receives No Objection Letter from Health Canada for Proof-of-Concept Trial
Jun 4, 2024 07:00AM ZYUS Life Sciences Receives Cannabis Drug License from Health Canada
May 7, 2024 06:52PM ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9
May 7, 2024 04:00PM ZYUS Announces Completion of Its Annual Filings
Apr 29, 2024 07:00AM ZYUS Announces Anticipated Delay in Its Annual Filings
Apr 23, 2024 07:00AM ZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain Management
Feb 1, 2024 07:00AM ZYUS Strengthens Expertise of Clinical Advisory Committee with the Appointment of Dr. Hance Clarke
Jan 9, 2024 07:00AM ZYUS Strengthens Leadership Team with Appointment of Vice President of Clinical Research
Dec 5, 2023 07:00AM ZYUS Life Sciences Corporation Announces Phase 2 Clinical Trial Evaluating Trichomylin® Softgel Capsules for Advanced Cancer Pain Management
Nov 29, 2023 10:48PM ZYUS Life Sciences Corporation Reports Q3 2023 Results
Nov 21, 2023 07:45AM ZYUS Life Sciences Corporation Announces Positive Phase I Clinical Trial Results for Trichomylin® Softgels
Oct 24, 2023 07:00AM ZYUS Life Sciences Corporation Announces New Director of Investor Relations and Capital Markets
Aug 31, 2023 07:45AM ZYUS Life Sciences Corporation Obtains Health Canada Security Clearance for New Board Member Wayne Brownlee
Jun 29, 2023 07:45AM ZYUS Life Sciences Strengthens Board of Directors with the Appointment of Wayne Brownlee